ConductScience.org, home

Trial · NCT03629886

Results by group62

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Subjects With Serious Adverse Events (SAEs) Related to Study Vaccine in Vacc-092 GroupVacc-092 Group0Participants
Number of Subjects With Potential Immune Mediated Diseases (pIMDs) in Vacc-092 GroupVacc-092 Group1Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupLive infant no apparent CA2Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupLive infant CA0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupElective termination no apparent CA8Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupElective termination CA0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupSpontaneous abortion no apparent CA0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupSpontaneous abortion CA0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupStillbirth no apparent CA0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupStillbirth CA0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupEctopic pregnancy0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupMolar pregnancy0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupLost to follow-up0Participants
Number of Pregnant Subjects Reported With Outcomes of Pregnancy in Vacc-092 GroupVacc-092 GroupPregnancy ongoing0Participants
Number of Subjects With SAEs in Vacc-092 GroupVacc-092 Group1Participants
Number of Subjects With Any Adverse Events or Serious Adverse Events (AE/SAE) Leading to Premature Discontinuation From the Study in Vacc-092 GroupVacc-092 Group0Participants
Number of Subjects With SAEs Related to Study Participation in All Study GroupsVacc-039 Group0Participants
Number of Subjects With SAEs Related to Study Participation in All Study GroupsVacc-092 Group0Participants
Incidence Rates of Incident Cervical Infection With HPV-16 and/or HPV-18 (by PCR) in HPV DNA Negative and Seronegative Subjects at Baseline in All Study GroupsVacc-039 GroupHPV-160.1395% Confidence Interval 0.07 to 0.21events per 100 person-years
Incidence Rates of Incident Cervical Infection With HPV-16 and/or HPV-18 (by PCR) in HPV DNA Negative and Seronegative Subjects at Baseline in All Study GroupsVacc-092 GroupHPV-160.895% Confidence Interval 0.65 to 0.98events per 100 person-years

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03629886/results